Hyunjin Ju

T cell-based immunotherapy in solid tumors: mechanistic barriers and emerging opportunities.

Developing a mechanistic framework that combines intrinsic T cell reprogramming with adaptation to the tumor context will be crucial for extending durable T cell-mediated immunity to solid cancers.